Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1208)	7/11/2005 3:10:54 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

SUPG Has also continued on the nearterm uptrend that started on July 1 from the 4.80 level and it is trading above its Feb.,Mar.,Apr.,May,June & JUly Hs and seems headed to start closing some of its January 3 downgap.<g> The stock is up more than 4% and volume is more than 1.3M bigcharts.marketwatch.com SUPG's president and CEO, James S. Manuso, Ph.D.,is scheduled to present at the C.E. Unterberg Towbin "Emerging Growth Opportunities Conference" in NY on Wednesday. Bernard

To: Jibacoa who wrote (1208)	8/30/2005 11:06:01 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NTEC Seems to have found support at the $2.25 level. It is trying to get off the nearterm downtrend coming from its July 1- July 19 double top at the 4.49 level Volume has remained low in the last 45 days. If the stock can close its July 20 downgap at the $4 level, it could be a good % gain from present levels.Today it was up 9.62% on volume of 42,500 The R/R seems favorable at present levels. bigcharts.marketwatch.com On July 20 was when it announced that the FDA wants further information on its NDA for NE-180 on which NTEC was planning to start a PI for treatment of chemo-induced anemia. Bernard